Pathway Financial Advisors LLC Lava Therapeutics Nv Call Options Transaction History
Pathway Financial Advisors LLC
- $517 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LVTX
# of Institutions
22Shares Held
4.93MCall Options Held
50.2KPut Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$2.57 Million0.28% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.96MShares$2.43 Million2.02% of portfolio
-
Bruce & Co., Inc. Chicago, IL522KShares$647,1230.28% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$80,6000.0% of portfolio
-
Two Sigma Investments, LP New York, NY57.7KShares$71,5660.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $32M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...